CTC as a Bridge, Indian Experts Visit for Technical Training and Exchange

YZY welcomed Dr. Pradipd, an R&D expert of a large Indian multi-national company, for the slide reading training in June. He confirmed the cancer screening or diagnosis application of CTC Separator CTCBIOPSY-A10, combined with several indicators. Both parties have conducted in-depth technical exchanges and discussion.

Dr Pradipd visited the workshops and R&D laboratory, witnessed the solid R&D foundation of YZY cardiovascular and tumor gene detection reagents, the 4 CE lines cover tumor/cancer related gene detection kits and core technology equipment. The expert provided technical proposals on the accuracy of cancer detection in CTC, and scientific recommendations on qPCR kits.

Afterwards, we visited a tertiary hospital in Wuhan to see the clinical application of CTC in liver cancer. It shows that CTC Separator A10 improves the positive rate of early screening for liver cancer, dynamically monitors the risk of recurrence in liver cancer transplant patients, thus to timely adjusts treatment plans. Both parties have reached a consensus that the era of large-scale CTC applications is inevitably approaching, expecting more extensive cooperation in the the cancer field in Indian, to alleviate human suffering from Cancer!